Literature DB >> 32269686

The role of CXCL chemokine family in the development and progression of gastric cancer.

Xuyan Chen1, Renpin Chen1, Ruifang Jin1, Zhiming Huang1.   

Abstract

The chemokine (C-X-C motif) ligand (CXCL) family plays an important role in inflammation. In order to understand the role of CXC chemokine family in carcinogenesis, this study explored a group of early gastric cancer (GC) patients, and assessed the level of CXC chemokine ligand (CXCL) in blood samples of patients representing systemic circulation and tumor microenvironment, detected the expression of CXC chemokine receptor (CXCR) in tumor tissues, and measured tumor infiltrating immune cell subsets. 69 patients with GC were included in a single center prospective study and were followed up for 6 years. The level of CXCL1-14 was determined by ELISA and the concentration gradient of chemokine was calculated. Western blot was used to detect the expression of CXCR1, CXCR2, CXCR3, and CXCR4 in tumor tissue. CXCL1-14 expression was inhibited by siRNA in HGC27 cells and then the migration ability of HGC27 cells was detected by cell scratch test. The results of this study showed that the chemokine concentrations of CXCL1, CXCL2, CXCL5, CXCL8, CXCL11, and CXCL13 in peripheral blood and tumor drainage blood of patients without recurrence after treatment were significantly lower than those before treatment. The concentrations of CXCL1, CXCL2, CXCL4, CXCL5, CXCL7, CXCL8, CXCL9, CXCL10, CXCL12, CXCL13, and CXCL14 in peripheral blood and tumor drainage blood were significantly higher than those in patients without recurrence. Patients with low expression of CXCR1 and CXCR3 had lower AFP (alpha fetoprotein), smaller tumor volume, and lower TNM tumor stage. Patients with lower expression of CXCR2 and CXCR4 had higher AFP (alpha fetoprotein) level, larger tumor volume, and higher TNM tumor stage. After down-regulation of CXCLs expression, the migration ability of most cell lines was significantly inhibited. This study suggests that CXCL chemokine family plays an important role in the pathogenesis of GC and can be used as a marker for the development of GC. IJCEP
Copyright © 2020.

Entities:  

Keywords:  CXCL; CXCR; chemokine; gastric cancer; prognosis

Year:  2020        PMID: 32269686      PMCID: PMC7137023     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  27 in total

Review 1.  Role of chemokines in metastatic niche: new insights along with a diagnostic and prognostic approach.

Authors:  Hadi Rezaeeyan; Reza Shirzad; Trevor D McKee; Najmaldin Saki
Journal:  APMIS       Date:  2018-04-20       Impact factor: 3.205

Review 2.  Role of chemokine pathways in hepatobiliary cancer.

Authors:  Josef Ehling; Frank Tacke
Journal:  Cancer Lett       Date:  2015-06-26       Impact factor: 8.679

Review 3.  The use of cytokines and chemokines in the cancer immunotherapy.

Authors:  Amedeo Amedei; Domenico Prisco; Mario M D' Elios
Journal:  Recent Pat Anticancer Drug Discov       Date:  2013-05       Impact factor: 4.169

Review 4.  Gastric cancer: prevention, screening and early diagnosis.

Authors:  Victor Pasechnikov; Sergej Chukov; Evgeny Fedorov; Ilze Kikuste; Marcis Leja
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

Review 5.  Chemokines in cancer.

Authors:  Melvyn T Chow; Andrew D Luster
Journal:  Cancer Immunol Res       Date:  2014-12       Impact factor: 11.151

6.  Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma.

Authors:  Xiaoguang Li; Wenbo Yao; Ya Yuan; Peizhan Chen; Bin Li; Jingquan Li; Ruiai Chu; Haiyun Song; Dong Xie; Xiaoqing Jiang; Hui Wang
Journal:  Gut       Date:  2015-10-09       Impact factor: 23.059

Review 7.  New blood markers detection technology: A leap in the diagnosis of gastric cancer.

Authors:  Maneesh K Beeharry; Wen-Tao Liu; Min Yan; Zheng-Gang Zhu
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

8.  Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer.

Authors:  Chao Lin; Hongyong He; Hao Liu; Ruochen Li; Yifan Chen; Yangyang Qi; Qi Jiang; Lingli Chen; Peipei Zhang; Heng Zhang; He Li; Weijuan Zhang; Yihong Sun; Jiejie Xu
Journal:  Gut       Date:  2019-01-19       Impact factor: 23.059

9.  Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinoma.

Authors:  Ishan Roy; Kathleen A Boyle; Emily P Vonderhaar; Noah P Zimmerman; Egal Gorse; A Craig Mackinnon; Rosa F Hwang; Janusz Franco-Barraza; Edna Cukierman; Susan Tsai; Douglas B Evans; Michael B Dwinell
Journal:  Lab Invest       Date:  2017-01-16       Impact factor: 5.662

10.  Correction: Marcuzzi, E., et al. Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization. Int. J. Mol. Sci. 2019, 20, 96.

Authors:  Elisabetta Marcuzzi; Roberta Angioni; Barbara Molon; Bianca Calì
Journal:  Int J Mol Sci       Date:  2019-05-29       Impact factor: 5.923

View more
  22 in total

1.  Chemokine (C-X-C motif) ligand 1 maintains the immune surveillance function of natural killer cells via the PDK2/mTOR signaling pathway.

Authors:  Xiaokang Zeng; Xinhuai Dong; Yanning Ma; Jie Yao
Journal:  Cell Biol Toxicol       Date:  2022-03-19       Impact factor: 6.691

2.  The functions and prognostic values of chemokine and chemokine receptors in gastric cancer.

Authors:  Chenglong He; Liping He; Qiaowei Lu; Jianjun Xiao; Wenjing Dong
Journal:  Am J Cancer Res       Date:  2022-07-15       Impact factor: 5.942

3.  Cellular Senescence-Related Genes: Predicting Prognosis in Gastric Cancer.

Authors:  Longfei Dai; Xu Wang; Tao Bai; Jianjun Liu; Bo Chen; Wenqi Yang
Journal:  Front Genet       Date:  2022-06-01       Impact factor: 4.772

4.  Pancreatic adenocarcinoma associated immune-gene signature as a novo risk factor for clinical prognosis prediction in hepatocellular carcinoma.

Authors:  Lei Dai; Joseph Mugaanyi; Xingchen Cai; Caide Lu; Changjiang Lu
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

5.  Bioinformatics Analysis of Prognostic Significance and Immune Characteristics of CXC Chemokine Family in Patients with Lung Adenocarcinoma.

Authors:  Dachen Bian; Yanhua Chen
Journal:  Comput Math Methods Med       Date:  2022-07-06       Impact factor: 2.809

Review 6.  The Role of Chemokines in the Development of Gastric Cancer - Diagnostic and Therapeutic Implications.

Authors:  Elzbieta Pawluczuk; Marta Łukaszewicz-Zając; Barbara Mroczko
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

7.  Serum CXCL13 Level is Associated with Tumor Progression and Unfavorable Prognosis in Penile Cancer.

Authors:  Miao Mo; Shiyu Tong; Tao Li; Xiongbing Zu; Xiheng Hu
Journal:  Onco Targets Ther       Date:  2020-08-31       Impact factor: 4.147

8.  Landscape and dynamics of single tumor and immune cells in early and advanced-stage lung adenocarcinoma.

Authors:  Zhencong Chen; Yiwei Huang; Zhengyang Hu; Mengnan Zhao; Ming Li; Guoshu Bi; Yuansheng Zheng; Jiaqi Liang; Tao Lu; Wei Jiang; Songtao Xu; Cheng Zhan; Junjie Xi; Qun Wang; Lijie Tan
Journal:  Clin Transl Med       Date:  2021-03

9.  Comprehensive analysis of prognostic gene signatures based on immune infiltration of ovarian cancer.

Authors:  Shibai Yan; Juntao Fang; Yongcai Chen; Yong Xie; Siyou Zhang; Xiaohui Zhu; Feng Fang
Journal:  BMC Cancer       Date:  2020-12-07       Impact factor: 4.430

10.  Platelet factor 4 inhibits human hair follicle growth and promotes androgen receptor expression in human dermal papilla cells.

Authors:  Ke Sha; Mengting Chen; Fangfen Liu; San Xu; Ben Wang; Qinqin Peng; Yiya Zhang; Hongfu Xie; Ji Li; Zhili Deng
Journal:  PeerJ       Date:  2020-09-04       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.